Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-126,150
Closed -$3.8M 1235
2022
Q1
$3.8M Buy
126,150
+14,700
+13% +$458K 0.01% 723
2021
Q4
$3.2M Sell
111,450
-43,556
-28% -$1.42M 0.01% 765
2021
Q3
$6.23M Sell
155,006
-824
-0.5% -$36.8K 0.02% 624
2021
Q2
$6.79M Buy
155,830
+17,428
+13% +$721K 0.02% 632
2021
Q1
$5.21M Buy
138,402
+2,400
+2% +$102K 0.02% 698
2020
Q4
$5.39M Buy
136,002
+1,928
+1% +$78.8K 0.02% 674
2020
Q3
$5.59M Sell
134,074
-3,210
-2% -$147K 0.02% 592
2020
Q2
$5.77M Sell
137,284
-24,683
-15% -$757K 0.02% 575
2020
Q1
$3.12M Buy
161,967
+35,825
+28% +$1.21M 0.02% 641
2019
Q4
$4.86M Buy
+126,142
New +$4.74M 0.02% 626

Other funds holding XP

Axa's XP Position: Q2 2022 in Review

Axa sold out of XP (XP) in Q2 2022, closing a stake of 126,150 shares — an estimated $3.8M sold.

Axa first reported a position in XP in Q4 2019 and held it in 10 quarters. The position peaked at $6.79M in Q2 2021. 200 funds tracked by Wall St. Rank hold XP as of Q2 2022.

  • Axa reported no remaining XP position as of Q2 2022 after selling out during the quarter.
  • Axa sold 126,150 XP shares in Q2 2022, an estimated $3.8M.
  • Axa first reported a position in XP in Q4 2019 and held it in 10 quarters.
  • Axa's XP position peaked at $6.79M in Q2 2021.
  • 200 funds tracked by Wall St. Rank held XP as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.